Trial intelligence / Profile preview

Vaginal Progesterone and Aspirin in Recurrent Preterm Birth

NCT05319834Phase 4Completed

Sponsor
Menoufia University
Start
Apr 2022
Primary completion
Dec 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of aspirin in preterm birth, sponsored by Menoufia University. Started Apr 2022; status: completed.

02

Drugs

aspirin
03

Conditions

preterm birth

Beyond the preview

Go deeper on NCT05319834.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05319834.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call